Atlas Trials

Best EGFR-TKI Sequence in NSCLC Harboring EGFR Mutations

Clinical trial NCT04811001 · UNKNOWN

Trial details

NCT number
NCT04811001
Sponsor
Fondazione Ricerca Traslazionale
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
NSCLC
Start date
2020-06-12
Primary completion
2023-12-31
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.